17-43774881-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_004090.4(DUSP3):c.183C>T(p.Asn61=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00219 in 1,614,198 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 4 hom. )
Consequence
DUSP3
NM_004090.4 synonymous
NM_004090.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.421
Genes affected
DUSP3 (HGNC:3069): (dual specificity phosphatase 3) The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene maps in a region that contains the BRCA1 locus which confers susceptibility to breast and ovarian cancer. Although DUSP3 is expressed in both breast and ovarian tissues, mutation screening in breast cancer pedigrees and in sporadic tumors was negative, leading to the conclusion that this gene is not BRCA1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 17-43774881-G-A is Benign according to our data. Variant chr17-43774881-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2647815.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.421 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUSP3 | NM_004090.4 | c.183C>T | p.Asn61= | synonymous_variant | 2/3 | ENST00000226004.8 | NP_004081.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUSP3 | ENST00000226004.8 | c.183C>T | p.Asn61= | synonymous_variant | 2/3 | 1 | NM_004090.4 | ENSP00000226004 | P1 | |
DUSP3 | ENST00000590342.1 | c.*330C>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/4 | 1 | ENSP00000467424 | ||||
DUSP3 | ENST00000590935.1 | c.60C>T | p.Asn20= | synonymous_variant | 1/3 | 5 | ENSP00000468604 | |||
DUSP3 | ENST00000591618.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00209 AC: 318AN: 152190Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
318
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00191 AC: 481AN: 251378Hom.: 3 AF XY: 0.00197 AC XY: 267AN XY: 135874
GnomAD3 exomes
AF:
AC:
481
AN:
251378
Hom.:
AF XY:
AC XY:
267
AN XY:
135874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00220 AC: 3210AN: 1461890Hom.: 4 Cov.: 32 AF XY: 0.00223 AC XY: 1624AN XY: 727244
GnomAD4 exome
AF:
AC:
3210
AN:
1461890
Hom.:
Cov.:
32
AF XY:
AC XY:
1624
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00209 AC: 318AN: 152308Hom.: 1 Cov.: 32 AF XY: 0.00222 AC XY: 165AN XY: 74486
GnomAD4 genome
AF:
AC:
318
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
165
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | DUSP3: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at